444 related articles for article (PubMed ID: 26196513)
21. Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.
Dawson RM; McAllister J; Liu CQ
Int J Antimicrob Agents; 2010 Oct; 36(4):359-63. PubMed ID: 20692130
[TBL] [Abstract][Full Text] [Related]
22. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments.
Nagant C; Pitts B; Nazmi K; Vandenbranden M; Bolscher JG; Stewart PS; Dehaye JP
Antimicrob Agents Chemother; 2012 Nov; 56(11):5698-708. PubMed ID: 22908164
[TBL] [Abstract][Full Text] [Related]
23. Antibiofilm properties of cathelicidin LL-37: an in-depth review.
Memariani H; Memariani M
World J Microbiol Biotechnol; 2023 Feb; 39(4):99. PubMed ID: 36781570
[TBL] [Abstract][Full Text] [Related]
24. Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients.
Pompilio A; Scocchi M; Pomponio S; Guida F; Di Primio A; Fiscarelli E; Gennaro R; Di Bonaventura G
Peptides; 2011 Sep; 32(9):1807-14. PubMed ID: 21849157
[TBL] [Abstract][Full Text] [Related]
25. Membrane phase characteristics control NA-CATH activity.
Samuel R; Gillmor S
Biochim Biophys Acta; 2016 Sep; 1858(9):1974-1982. PubMed ID: 27216315
[TBL] [Abstract][Full Text] [Related]
26. The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii.
Feng X; Sambanthamoorthy K; Palys T; Paranavitana C
Peptides; 2013 Nov; 49():131-7. PubMed ID: 24071034
[TBL] [Abstract][Full Text] [Related]
27. In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides.
Kanthawong S; Nazmi K; Wongratanacheewin S; Bolscher JG; Wuthiekanun V; Taweechaisupapong S
Int J Antimicrob Agents; 2009 Oct; 34(4):309-14. PubMed ID: 19577435
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural effects and antibiofilm activity of LFchimera against Burkholderia pseudomallei.
Puknun A; Kanthawong S; Anutrakunchai C; Nazmi K; Tigchelaar W; Hoeben KA; Veerman EC; Bolscher JG; Taweechaisupapong S
World J Microbiol Biotechnol; 2016 Feb; 32(2):33. PubMed ID: 26754671
[TBL] [Abstract][Full Text] [Related]
29. Quorum Sensing Influences Burkholderia thailandensis Biofilm Development and Matrix Production.
Tseng BS; Majerczyk CD; Passos da Silva D; Chandler JR; Greenberg EP; Parsek MR
J Bacteriol; 2016 Oct; 198(19):2643-50. PubMed ID: 27068594
[TBL] [Abstract][Full Text] [Related]
30. A Recombinant Snake Cathelicidin Derivative Peptide: Antibiofilm Properties and Expression in
Tajbakhsh M; Akhavan MM; Fallah F; Karimi A
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30360422
[TBL] [Abstract][Full Text] [Related]
31. Cathelicidin Peptides Restrict Bacterial Growth via Membrane Perturbation and Induction of Reactive Oxygen Species.
Rowe-Magnus DA; Kao AY; Prieto AC; Pu M; Kao C
mBio; 2019 Sep; 10(5):. PubMed ID: 31506312
[TBL] [Abstract][Full Text] [Related]
32. Marsupial and monotreme cathelicidins display antimicrobial activity, including against methicillin-resistant Staphylococcus aureus.
Peel E; Cheng Y; Djordjevic JT; Kuhn M; Sorrell T; Belov K
Microbiology (Reading); 2017 Oct; 163(10):1457-1465. PubMed ID: 28949902
[TBL] [Abstract][Full Text] [Related]
33. LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.
Kim EY; Rajasekaran G; Shin SY
Eur J Med Chem; 2017 Aug; 136():428-441. PubMed ID: 28525841
[TBL] [Abstract][Full Text] [Related]
34. The structure and behavior of the NA-CATH antimicrobial peptide with liposomes.
Du H; Samuel RL; Massiah MA; Gillmor SD
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2394-405. PubMed ID: 26205847
[TBL] [Abstract][Full Text] [Related]
35. Membrane-active mechanism of LFchimera against Burkholderia pseudomallei and Burkholderia thailandensis.
Kanthawong S; Puknun A; Bolscher JG; Nazmi K; van Marle J; de Soet JJ; Veerman EC; Wongratanacheewin S; Taweechaisupapong S
Biometals; 2014 Oct; 27(5):949-56. PubMed ID: 24961697
[TBL] [Abstract][Full Text] [Related]
36. Structural and functional characterization of CATH_BRALE, the defense molecule in the ancient salmonoid, Brachymystax lenok.
Li Z; Zhang S; Gao J; Guang H; Tian Y; Zhao Z; Wang Y; Yu H
Fish Shellfish Immunol; 2013 Jan; 34(1):1-7. PubMed ID: 23390641
[TBL] [Abstract][Full Text] [Related]
37. Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation.
De Brucker K; Delattin N; Robijns S; Steenackers H; Verstraeten N; Landuyt B; Luyten W; Schoofs L; Dovgan B; Fröhlich M; Michiels J; Vanderleyden J; Cammue BP; Thevissen K
Antimicrob Agents Chemother; 2014 Sep; 58(9):5395-404. PubMed ID: 24982087
[TBL] [Abstract][Full Text] [Related]
38. Interaction of blood components with cathelicidins and their modified versions.
Yu K; Lai BF; Gani J; Mikut R; Hilpert K; Kizhakkedathu JN
Biomaterials; 2015 Nov; 69():201-11. PubMed ID: 26295533
[TBL] [Abstract][Full Text] [Related]
39. Characterization and functional analysis of cathelicidin-MH, a novel frog-derived peptide with anti-septicemic properties.
Chai J; Chen X; Ye T; Zeng B; Zeng Q; Wu J; Kascakova B; Martins LA; Prudnikova T; Smatanova IK; Kotsyfakis M; Xu X
Elife; 2021 Apr; 10():. PubMed ID: 33875135
[TBL] [Abstract][Full Text] [Related]
40. Tree Frog-Derived Cathelicidin Protects Mice against Bacterial Infection through Its Antimicrobial and Anti-Inflammatory Activities and Regulatory Effect on Phagocytes.
He Y; Shen Y; Feng X; Ruan S; Zhao Y; Mu L; Wu J; Yang H
ACS Infect Dis; 2023 Nov; 9(11):2252-2268. PubMed ID: 37855266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
